Glabridin vs Tranexamic Acid: Understanding Different Approaches to Hyperpigmentation

When developing a pigmentation-focused cosmetic formula, ingredient selection is rarely as simple as choosing the active with the strongest published result.

A common question from formulation teams is: “Should we choose glabridin or tranexamic acid for a brightening formulation?”

Factory supply

Tranexamic Acid

View product Contact Us

The more useful question is usually different: What pigmentation pathway are we trying to influence, and which ingredient fits the formulation strategy?

Glabridin and tranexamic acid are both widely used in discussions around hyperpigmentation ingredients, but they come from different scientific backgrounds. Their biological targets, formulation properties, and application considerations are not the same.

For cosmetic scientists, understanding these differences helps avoid a common mistake: comparing ingredients only by one test result or one marketing claim.

1. Different Ingredient Backgrounds

Glabridin is a flavonoid derived from licorice (Glycyrrhiza glabra) and has been studied mainly in relation to melanogenesis regulation.

Tranexamic acid is a synthetic amino acid derivative originally developed for medical applications related to antifibrinolytic activity. In cosmetic applications, it has been investigated mainly in relation to pigmentation processes associated with inflammatory and environmental triggers.

Although both ingredients may appear in brightening products, they are not interchangeable from a formulation development perspective.

2. Different Biological Targets Behind Pigmentation Research

Pigmentation is a complex biological process involving multiple steps:

• Melanin synthesis
• Melanocyte activity
• Communication between skin cells
• Inflammatory signaling
• External stress responses

Because pigmentation involves multiple biological events, cosmetic ingredients are often evaluated from different angles. A tyrosinase inhibitor and an ingredient associated with inflammatory pigmentation pathways are answering completely different scientific questions.

3. Glabridin Mechanism: Focus on Melanogenesis Regulation

The glabridin mechanism is mainly discussed around melanogenesis-related pathways. Research has investigated its influence on tyrosinase activity, melanin synthesis processes, and melanocyte-related responses.

One frequently referenced study by Yokota et al. evaluated glabridin and other compounds using a tyrosinase inhibition model. Reported IC50 values under the experimental conditions were:

These results demonstrate strong activity in an enzyme-based screening model. However, formulation scientists should be careful when interpreting this type of data.

An enzyme assay provides information about a specific interaction. It does not directly predict the performance of a finished cosmetic formula. In practical development work, other factors become equally important:

• Active concentration in the final product
• Solubility and dispersion
• Skin delivery
• Formula stability
• Interaction with other ingredients

4. Tranexamic Acid: Focus on Pigmentation Signaling

Tranexamic acid cosmetic ingredient research follows a different direction. Instead of primarily focusing on direct melanogenesis-related enzyme activity, research has explored its relationship with pigmentation processes influenced by:

• Inflammatory mediators
• Skin stress responses
• Melanocyte activation signals

This approach is particularly relevant when studying pigmentation conditions where inflammation or external stimulation may contribute to uneven pigmentation development.

The Strategic Difference:
Glabridin is often considered from the perspective of regulating pigment production pathways.
Tranexamic acid is often considered from the perspective of modifying signals involved in pigment activation.
Neither approach replaces the other. They represent different ways of understanding pigmentation biology.

5. Evidence Comparison: Understanding What the Data Shows

When comparing brightening active ingredients, the type of evidence matters. Different studies answer different questions.

A common mistake in ingredient comparison is putting all evidence into one ranking system. For R&D teams, the question is not simply whether an ingredient has activity. The question is whether the evidence matches the intended product concept.

6. Formulation Considerations: Solubility Changes the Strategy

Biological activity is only one part of ingredient selection. The physical properties of an ingredient often determine how easily it can be incorporated into a formula.

Formulating with Glabridin

Glabridin is a lipophilic compound. Typical formulation considerations include:

• Solubilization strategy & dispersion quality
• Compatibility with oil phases
• Protection against stability challenges

Depending on the product system, lipid-compatible forms may fit certain emulsion systems, while water-dispersible forms may expand application possibilities in aqueous formulas. The challenge is not simply that glabridin is “difficult to use”, but rather that the formulation approach needs to match the ingredient characteristics.

Formulating with Tranexamic Acid

Tranexamic acid has high water solubility, which can make incorporation into aqueous formulations relatively straightforward. However, formulators still need to evaluate:

• pH compatibility
• Interaction with other active ingredients
• Preservation system compatibility
• Long-term stability

A water-soluble ingredient is not automatically problem-free. The final formula environment determines whether the active remains stable and performs as expected.

7. Choosing Between the Two: A Practical Comparison

A practical comparison is not about identifying a universal winner. It is about matching the ingredient to the development objective.

8. Can They Be Used Together?

Combining different brightening active ingredients is common in cosmetic development. However, adding more actives does not automatically create a better formula.

Before combining glabridin and tranexamic acid, development teams should evaluate:

• Compatibility and Stability
• Effective concentration range
• Sensory impact
• Supporting evidence

A rational combination strategy should be based on complementary roles. The goal is to design a formula where each component has a clear purpose.

9. A Formulator’s Perspective: Ingredient Selection Is About Strategy

For cosmetic scientists, the more meaningful comparison is not “Which ingredient is stronger?” It is: “Which biological approach and formulation system fit the product objective?”

Understanding this difference allows ingredient buyers, formulators, and product developers to make more rational decisions when evaluating hyperpigmentation ingredients.

Frequently Asked Questions

References

1. Yokota T, Nishio H, Kubota Y, Mizoguchi M. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Research. 1998.
2. Nerya O, Vaya J, Musa R, et al. Glabrene and isoliquiritigenin as tyrosinase inhibitors from licorice roots. Journal of Agricultural and Food Chemistry. 2003.
3. D’Mello SAN, Finlay GJ, Baguley BC, Askarian-Amiri ME. Signaling Pathways in Melanogenesis. International Journal of Molecular Sciences. 2016;17(7):1144.
4. Tse TW, Hui E. Tranexamic acid: an important emerging agent in the treatment of melasma. Journal of Clinical and Aesthetic Dermatology. 2013;6(7):42-44.
5. Lee AY. Recent progress in melasma pathogenesis. Pigment Cell & Melanoma Research. 2015;28(6):648-660.